XML 23 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Share-based Compensation
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(
7
)
Share-Based Compensation
 
The share-based compensation expense is recorded in cost of goods sold, research and development, and selling, general and administrative expenses based on the employee's respective function.
No
share-based compensation was capitalized during the periods presented. Share-based compensation expense for the
three
and
nine
months ended
September 30, 2018
and
2017
was recorded as follows (in thousands):
  
   
Three months ended
September
30,
   
Nine
months ended
September
30,
 
   
2018
   
2017
   
2018
   
2017
 
Cost of goods sold
  $
39
    $
33
    $
105
    $
107
 
Research and development
   
250
     
172
     
711
     
498
 
Selling, general and administrative
   
441
     
496
     
1,267
     
1,394
 
Share-based compensation expense
  $
730
    $
701
    $
2,083
    $
1,999
 
 
 
The following table summarizes the activity of stock options and related information:
 
   
 
Number of
options
outstanding
   
Weighted
average
exercise
price
 
Balance, December 31, 2017
   
4,213,100
    $
2.96
 
Stock options granted
   
1,698,452
     
2.41
 
Stock options exercised
   
(2,488
)
   
1.80
 
Stock options cancelled
   
(359,958
)
   
2.93
 
Balance, September 30, 2018
   
5,549,106
    $
2.80
 
 
The weighted average grant-date fair value of options granted during the
nine
months ended
September 30, 2018
was
$1.72
per share.
 
Employee Share-Based Compensation (Stock Options)
 
During the
nine
months ended
September 30, 2018,
we granted stock options to certain non-employee directors and employees to purchase
1,698,452
 shares of common stock. The fair value of each option grant was estimated on the date of the grant using the Black-Scholes option pricing model with the following assumptions:  
 
Risk-free interest rate
 2.66%
-
2.87%
 
Volatility
 81%
-
82%
 
Dividend yield
 
None
 
 
Expected term (in years)
 
6.25
 
 
 
Unrecognized share-based compensation for employee options as of
September 30, 2018
was approximately
$5.6
million to be recognized over a remaining weighted average service period of
2.7
years. 
 
Restricted Stock Units (RSUs)
 
The following summarizes the activity of non-vested RSUs:
 
   
 
Number of
shares
   
Weighted
average
grant date
fair value
per share
 
Balance, December 31, 2017
   
97,996
    $
8.71
 
RSUs granted
   
226,471
     
1.36
 
RSUs vested
   
(57,108
)
   
7.03
 
Balance, September 30, 2018
   
267,359
    $
2.84
 
 
Unrecognized share-based compensation for employee RSUs granted as of
September 30, 2018
was approximately
$292,000
to be recognized over a remaining weighted average service period of
1.3
years.
 
Nonemployee Share-Based Compensation
 
During the
nine
months ended
September 30, 2018,
we did
not
grant any options to purchase shares of common stock to consultants. Options granted to consultants have been granted in exchange for consulting services to be rendered and vest over the term specified in the grant, which correlates to the period the services are rendered. We recorded
$74,000
and
$188,000
for the
three
months ended
September 30, 2018
and
2017,
respectively, and
$150,000
and
$698,000
for the
nine
months ended
September 30, 2018
and
2017,
respectively as nonemployee share-based compensation expense.
 
We account for share-based compensation arrangements with nonemployees, using the Black-Scholes option pricing model, based on the fair value as these instruments vest. Accordingly, at each reporting date, we revalue the unearned portion of the share-based compensation and the resulting change in fair value is recognized in the consolidated statements of operations over the period the related services are rendered. The following assumptions were used to value the awards for the
nine
months ended
September 30, 2018:
 
Risk-free interest rate
 2.80%
 -
2.84%
 
Volatility
  78%
-
85%
 
Dividend yield
 
None
 
 
Expected term (in years)
  7.9
-
8.8